Ranger Investment Management L.P. Buys 470,132 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Ranger Investment Management L.P. boosted its stake in Option Care Health, Inc. (NASDAQ:OPCH) by 112.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 888,495 shares of the company’s stock after purchasing an additional 470,132 shares during the quarter. Option Care Health comprises about 1.8% of Ranger Investment Management L.P.’s holdings, making the stock its 26th biggest position. Ranger Investment Management L.P. owned 0.50% of Option Care Health worth $29,933,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently bought and sold shares of OPCH. Mutual of America Capital Management LLC grew its stake in Option Care Health by 63.3% in the fourth quarter. Mutual of America Capital Management LLC now owns 190,684 shares of the company’s stock valued at $6,424,000 after acquiring an additional 73,938 shares during the period. Westfield Capital Management Co. LP increased its position in shares of Option Care Health by 19.6% during the fourth quarter. Westfield Capital Management Co. LP now owns 4,482,732 shares of the company’s stock worth $151,023,000 after acquiring an additional 735,344 shares in the last quarter. Principal Financial Group Inc. raised its holdings in shares of Option Care Health by 6.9% in the 4th quarter. Principal Financial Group Inc. now owns 968,233 shares of the company’s stock worth $32,620,000 after acquiring an additional 62,449 shares during the last quarter. Wellington Management Group LLP lifted its position in Option Care Health by 15.9% in the 3rd quarter. Wellington Management Group LLP now owns 2,896,392 shares of the company’s stock valued at $93,698,000 after acquiring an additional 397,627 shares in the last quarter. Finally, HealthInvest Partners AB bought a new position in Option Care Health in the 4th quarter valued at about $1,254,000. 98.05% of the stock is owned by institutional investors.

Option Care Health Stock Performance

Shares of NASDAQ OPCH traded up $0.09 during midday trading on Friday, reaching $29.19. The company’s stock had a trading volume of 1,217,773 shares, compared to its average volume of 1,103,266. The company has a debt-to-equity ratio of 0.74, a current ratio of 1.77 and a quick ratio of 1.39. The stock has a market capitalization of $5.07 billion, a P/E ratio of 19.20, a PEG ratio of 1.42 and a beta of 1.31. The firm has a 50 day moving average price of $30.26 and a 200-day moving average price of $31.48. Option Care Health, Inc. has a 12-month low of $26.17 and a 12-month high of $35.74.

Option Care Health (NASDAQ:OPCH) last announced its quarterly earnings data on Tuesday, April 23rd. The company reported $0.26 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.22 by $0.04. The firm had revenue of $1.15 billion during the quarter, compared to the consensus estimate of $1.10 billion. Option Care Health had a return on equity of 18.92% and a net margin of 6.15%. The business’s revenue for the quarter was up 12.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.21 EPS. As a group, equities analysts predict that Option Care Health, Inc. will post 1.19 earnings per share for the current year.

Analysts Set New Price Targets

Several analysts have recently commented on the company. Barrington Research reissued an “outperform” rating and issued a $38.00 price objective on shares of Option Care Health in a research note on Wednesday, April 24th. Jefferies Financial Group upped their target price on shares of Option Care Health from $36.00 to $38.00 and gave the stock a “buy” rating in a research note on Monday, March 4th.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.